Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
65
CNA Quote, Financials, Valuation and Earnings
Last price:
$47.91
Seasonality move
:
6.34%
Day range:
$47.70 - $48.05
52-week range:
$43.29 - $51.34
Dividend yield:
3.84%
P/E ratio:
13.08x
P/S ratio:
0.88x
P/B ratio:
1.14x
Volume:
139.9K
Avg. volume:
454.2K
1-year change:
-1.52%
Market cap:
$13B
Revenue:
$14.3B
EPS (TTM):
$3.66
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.8B | $11.9B | $11.9B | $13.3B | $14.3B | |
| Revenue Growth (YoY) | 0.38% | 10.18% | -0.24% | 11.95% | 7.3% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $1.3B | $1.5B | $1.6B | $1.7B | $1.6B | |
| Operating Expenses | -$943M | -$1.6B | -$926M | -$1.6B | -$1.3B | |
| Operating Income | $943M | $1.6B | $926M | $1.6B | $1.3B | |
| Net Interest Expenses | $122M | $113M | $112M | $127M | $133M | |
| EBT. Incl. Unusual Items | $821M | $1.5B | $814M | $1.5B | $1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $131M | $282M | $132M | $313M | $252M | |
| Net Income to Company | $690M | $1.2B | $682M | $1.2B | $959M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $690M | $1.2B | $682M | $1.2B | $959M | |
| Basic EPS (Cont. Ops) | $2.54 | $4.42 | $2.51 | $4.44 | $3.53 | |
| Diluted EPS (Cont. Ops) | $2.53 | $4.41 | $2.50 | $4.43 | $3.52 | |
| Weighted Average Basic Share | $271.6M | $271.8M | $271.6M | $271.3M | $271.5M | |
| Weighted Average Diluted Share | $272.4M | $272.8M | $272.5M | $272.2M | $272.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $821M | $1.5B | $814M | $1.5B | $1.2B | |
| Revenue (Reported) | $10.8B | $11.9B | $11.9B | $13.3B | $14.3B | |
| Operating Income (Reported) | $943M | $1.6B | $926M | $1.6B | $1.3B | |
| Operating Income (Adjusted) | $821M | $1.5B | $814M | $1.5B | $1.2B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | $3B | $3.3B | $3.6B | $3.8B | |
| Revenue Growth (YoY) | 4.93% | -0.07% | 12.82% | 8.45% | 5.5% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $365M | $410M | $415M | $409M | -- | |
| Operating Expenses | -$342M | $23M | -$360M | -$393M | -$549M | |
| Operating Income | $342M | -$23M | $360M | $393M | $549M | |
| Net Interest Expenses | $28M | $28M | $34M | $32M | $36M | |
| EBT. Incl. Unusual Items | $314M | -$51M | $326M | $361M | $513M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $58M | -$9M | $68M | $78M | $110M | |
| Net Income to Company | $256M | -$42M | $258M | $283M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $256M | -$42M | $258M | $283M | $403M | |
| Basic EPS (Cont. Ops) | $0.94 | -$0.15 | $0.95 | $1.04 | $1.49 | |
| Diluted EPS (Cont. Ops) | $0.94 | -$0.15 | $0.95 | $1.04 | $1.48 | |
| Weighted Average Basic Share | $271.7M | $271.4M | $271.2M | $271.3M | $271.1M | |
| Weighted Average Diluted Share | $272.7M | $271.4M | $272.3M | $272.7M | $272.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $314M | -$51M | $326M | $361M | $513M | |
| Revenue (Reported) | $3B | $3B | $3.3B | $3.6B | $3.8B | |
| Operating Income (Reported) | $342M | -$23M | $360M | $393M | $549M | |
| Operating Income (Adjusted) | $314M | -$51M | $326M | $361M | $513M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $11.8B | $11.8B | $12.9B | $14.1B | $14.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $1.4B | $1.6B | $1.7B | $1.6B | -- | |
| Operating Expenses | -$1.7B | -$973M | -$1.5B | -$1.8B | -$1.4B | |
| Operating Income | $1.7B | $973M | $1.5B | $1.8B | $1.4B | |
| Net Interest Expenses | $113M | $112M | $121M | $135M | $131M | |
| EBT. Incl. Unusual Items | $1.6B | $861M | $1.3B | $1.7B | $1.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $309M | $152M | $264M | $345M | $266M | |
| Net Income to Company | $1.3B | $691M | $1.1B | $1.3B | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.3B | $709M | $1.1B | $1.3B | $997M | |
| Basic EPS (Cont. Ops) | $4.87 | $2.61 | $3.97 | $4.81 | $3.68 | |
| Diluted EPS (Cont. Ops) | $4.85 | $2.60 | $3.96 | $4.79 | $3.66 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.6B | $861M | $1.3B | $1.7B | $1.3B | |
| Revenue (Reported) | $11.8B | $11.8B | $12.9B | $14.1B | $14.9B | |
| Operating Income (Reported) | $1.7B | $973M | $1.5B | $1.8B | $1.4B | |
| Operating Income (Adjusted) | $1.6B | $861M | $1.3B | $1.7B | $1.3B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $8.9B | $8.8B | $9.8B | $10.6B | $11.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $1.1B | $1.2B | $1.2B | $1.2B | $813M | |
| Operating Expenses | -$1.2B | -$615M | -$1.2B | -$1.3B | -$1.3B | |
| Operating Income | $1.2B | $615M | $1.2B | $1.3B | $1.3B | |
| Net Interest Expenses | $85M | $84M | $93M | $101M | $99M | |
| EBT. Incl. Unusual Items | $1.2B | $531M | $1.1B | $1.2B | $1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $218M | $88M | $220M | $252M | $266M | |
| Net Income to Company | $936M | $443M | $838M | $938M | $573M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $936M | $443M | $838M | $938M | $976M | |
| Basic EPS (Cont. Ops) | $3.44 | $1.63 | $3.09 | $3.45 | $3.60 | |
| Diluted EPS (Cont. Ops) | $3.43 | $1.62 | $3.08 | $3.44 | $3.58 | |
| Weighted Average Basic Share | $815.5M | $814.9M | $813.7M | $814.5M | $813.5M | |
| Weighted Average Diluted Share | $818.4M | $816.9M | $816.6M | $818M | $817.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.2B | $531M | $1.1B | $1.2B | $1.2B | |
| Revenue (Reported) | $8.9B | $8.8B | $9.8B | $10.6B | $11.2B | |
| Operating Income (Reported) | $1.2B | $615M | $1.2B | $1.3B | $1.3B | |
| Operating Income (Adjusted) | $1.2B | $531M | $1.1B | $1.2B | $1.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $419M | $536M | $475M | $345M | $472M | |
| Short Term Investments | $1.9B | $2B | $39.5B | $2.2B | $2.1B | |
| Accounts Receivable, Net | $7.1B | $8.4B | $8.6B | $8.9B | $9.7B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $6.8B | $7.5B | $6.9B | $7.5B | $8.4B | |
| Property Plant And Equipment | $451M | $401M | $381M | $393M | $453M | |
| Long-Term Investments | $1.7B | $2B | $2B | $2.3B | $2.6B | |
| Goodwill | $148M | $148M | $144M | $146M | $145M | |
| Other Intangibles | $69M | $67M | $71M | $78M | $77M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $60.2B | $61.7B | $55.8B | $59.6B | $60.8B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $18.3B | $18.8B | $16.9B | $18.5B | $19B | |
| Long-Term Debt | $3.1B | $3B | $2.8B | $2.7B | $3.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $47.5B | $48.9B | $47.2B | $49.7B | $50.3B | |
| Common Stock | $683M | $683M | $683M | $683M | $683M | |
| Other Common Equity Adj | $803M | $320M | -$3.6B | -$2.7B | -$2B | |
| Common Equity | $12.7B | $12.8B | $8.5B | $9.9B | $10.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $12.7B | $12.8B | $8.5B | $9.9B | $10.5B | |
| Total Liabilities and Equity | $60.2B | $61.7B | $55.8B | $59.6B | $60.8B | |
| Cash and Short Terms | $2.3B | $2.5B | $39.9B | $2.5B | $2.6B | |
| Total Debt | $3.1B | $3B | $2.8B | $2.7B | $3.2B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $625M | $503M | $485M | $456M | $483M | |
| Short Term Investments | $1.1B | $1.1B | $3.1B | $3.5B | -- | |
| Accounts Receivable, Net | $8.1B | $8.7B | $8.7B | $9.3B | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $6.6B | $5.9B | $7.2B | $7.9B | $8.1B | |
| Property Plant And Equipment | $234M | $229M | $257M | $258M | $283M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $148M | $142M | $145M | $147M | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $61.2B | $54.5B | $56.5B | $61.6B | $63.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $793M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $18.5B | $19B | $18.2B | $18.8B | $20.6B | |
| Long-Term Debt | $2.8B | $2.8B | $2.5B | $3B | $3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $48.5B | $46.4B | $47.9B | $50.8B | $52B | |
| Common Stock | $683M | $683M | $683M | $683M | $683M | |
| Other Common Equity Adj | $346M | -$4.1B | -$3.7B | -$1.8B | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $12.7B | $8.1B | $8.6B | $10.8B | $11.3B | |
| Total Liabilities and Equity | $61.2B | $54.5B | $56.5B | $61.6B | $63.3B | |
| Cash and Short Terms | $1.8B | $1.6B | $3.5B | $3.9B | -- | |
| Total Debt | $2.8B | $2.8B | $2.5B | $3B | $3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $690M | $1.2B | $682M | $1.2B | $959M | |
| Depreciation & Amoritzation | $60M | $54M | $51M | $73M | $67M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$409M | -$1.4B | -$226M | -$245M | -$898M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.8B | $2B | $2.5B | $2.3B | $2.6B | |
| Capital Expenditures | $23M | $26M | $52M | $90M | $95M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$705M | -$1.2B | -$1.5B | -$1.8B | -$1.3B | |
| Dividends Paid (Ex Special Dividend) | $950M | $621M | $982M | $787M | $1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $495M | -- | -- | $491M | $490M | |
| Long-Term Debt Repaid | -$419M | -- | -- | -$243M | -$550M | |
| Repurchase of Common Stock | $18M | $18M | $39M | $24M | $20M | |
| Other Financing Activities | -$10M | -$9M | -$11M | -$14M | -$12M | |
| Cash From Financing | -$902M | -$648M | -$1B | -$577M | -$1.1B | |
| Beginning Cash (CF) | $419M | $536M | $475M | $345M | $472M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $177M | $117M | -$61M | -$130M | $127M | |
| Ending Cash (CF) | $605M | $649M | $395M | $220M | $589M | |
| Levered Free Cash Flow | $1.8B | $2B | $2.5B | $2.2B | $2.5B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $256M | -$42M | $258M | $283M | -- | |
| Depreciation & Amoritzation | $14M | $13M | $16M | $17M | $18M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $11M | $224M | $413M | $222M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $669M | $737M | $828M | $748M | $720M | |
| Capital Expenditures | $11M | $16M | $24M | $18M | $16M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$395M | -$641M | -$679M | -$553M | -$975M | |
| Dividends Paid (Ex Special Dividend) | $104M | $109M | $114M | $120M | $124M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $96M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $18M | -- | -- | -- | |
| Other Financing Activities | -- | -$11M | -- | -- | -- | |
| Cash From Financing | -$104M | -$138M | -$18M | -$120M | $369M | |
| Beginning Cash (CF) | $625M | $503M | $485M | $456M | $483M | |
| Foreign Exchange Rate Adjustment | -$7M | -$15M | -- | $6M | -$4M | |
| Additions / Reductions | $163M | -$57M | $127M | $81M | $110M | |
| Ending Cash (CF) | $781M | $431M | $612M | $543M | $589M | |
| Levered Free Cash Flow | $658M | $721M | $804M | $730M | $704M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.3B | $691M | $1.1B | $1.3B | -- | |
| Depreciation & Amoritzation | $55M | $51M | $57M | $80M | $69M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$1.2B | -$672M | $80M | -$565M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.7B | $2.6B | $2.3B | $2.4B | $2.6B | |
| Capital Expenditures | $23M | $51M | $78M | $80M | $96M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$895M | -$1.7B | -$2B | -$1.1B | -$2B | |
| Dividends Paid (Ex Special Dividend) | $618M | $977M | $781M | $1B | $1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $491M | $490M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $18M | $39M | $24M | $20M | $34M | |
| Other Financing Activities | -$10M | -$11M | -$12M | -$14M | -- | |
| Cash From Financing | -$646M | -$1B | -$326M | -$1.4B | -$597M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $183M | -$122M | -$18M | -$29M | $27M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.7B | $2.6B | $2.2B | $2.3B | $2.5B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $936M | $443M | $838M | $938M | $573M | |
| Depreciation & Amoritzation | $41M | $38M | $44M | $51M | $53M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$1.1B | -$390M | -$84M | -$404M | -$669M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.4B | $2B | $1.8B | $1.9B | $1.9B | |
| Capital Expenditures | $16M | $41M | $67M | $57M | $58M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$597M | -$1.1B | -$1.5B | -$762M | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | $518M | $874M | $673M | $906M | $922M | |
| Special Dividend Paid | $750K | $2M | $1.2M | $2M | $2M | |
| Long-Term Debt Issued | -- | -- | $491M | $490M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$550M | -- | |
| Repurchase of Common Stock | $18M | $39M | $24M | $20M | $34M | |
| Other Financing Activities | -$9M | -$11M | -$12M | -$12M | -$15M | |
| Cash From Financing | -$545M | -$924M | -$218M | -$998M | -$478M | |
| Beginning Cash (CF) | $1.7B | $1.4B | $1.3B | $1.2B | $1.3B | |
| Foreign Exchange Rate Adjustment | -$7M | -$27M | $4M | $3M | $15M | |
| Additions / Reductions | $206M | -$33M | $10M | $111M | $11M | |
| Ending Cash (CF) | $1.9B | $1.4B | $1.3B | $1.4B | $1.4B | |
| Levered Free Cash Flow | $1.3B | $1.9B | $1.7B | $1.8B | $1.9B | |
Get CNA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CNA
Sector
P/E ratio
13.08x
12.24x
PEG ratio
0.51x
0.31x
P/B ratio
1.14x
1.11x
Price / LTM sales
0.88x
1.85x
Growth Metrics
CNA
Sector
Revenue growth
5.5%
5.54%
Earnings growth
42.61%
14.85%
Revenue (5-year growth)
5.8%
8.85%
Earnings forecast
$1.32
$0.62
Profitability
CNA
Sector
Profitability FY 2024
--
--
Return on invested capital
7.21%
5.01%
Return on assets
1.61%
1.01%
Return on equity
9.31%
9.68%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Feb
9
Estimated Next Earnings Date
Feb
2
Balance Sheet
CNA
Sector
Total cash
$3.7B
$431.4M
Short term investments
$2.1B
$211.3M
Total assets
$60.8B
$3.1B
Long term debt
$3B
$79.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
